V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013734 | 270014365 | null | null | Disease modification (D) | 2016-05-02 | 2016-05-02 | CHOP R - 21 days | N | N | 270015585 | CHOP R |
| 270013735 | 270009346 | 1.76 | 104 | Curative (C) | 2016-03-12 | 2016-03-21 | CHOP R - 21 days | 2 | N | 270015589 | CHOP R |
| 270013736 | 270014366 | 1.81 | 97 | Curative (C) | 2016-09-14 | 2016-10-08 | DHAP | N | N | 270015591 | DHAP |
| 270013737 | 270009348 | 0 | 65 | Curative (C) | 2015-06-07 | 2015-06-08 | CHLVPP | N | N | 270015596 | CHLVPP |
| 270013738 | 270009349 | 1.77 | 78.2 | Curative (C) | 2013-12-27 | 2014-03-23 | CHOP R | 02 | N | 270015597 | CHOP R |
| 270013739 | 270014368 | 1.72 | null | Adjuvant (A) | 2015-07-31 | 2015-08-05 | Trifluridine + Tipiracil | 2 | N | 270015598 | TRIFLURIDINE + TIPIRACIL |
| 270013740 | 270014368 | 1.78 | 98.1 | Neo-adjuvant (N) | 2015-02-09 | 2015-02-14 | Capecitabine (21 day) + Irinotecan | N | null | 270015598 | CAPECITABINE + IRINOTECAN |
| 270013741 | 270009351 | 1.7 | null | null | 2014-10-28 | 2014-11-04 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 270015601 | NOT MATCHED |
| 270013742 | 270009352 | null | null | Curative (C) | 2014-07-17 | 2014-07-21 | DHAP | 02 | N | 270015610 | DHAP |
| 270013743 | 270009354 | null | 75.6 | Palliative (P) | 2015-12-03 | 2016-02-04 | Capecitabine (14 day) + Irinotecan | N | N | 270015612 | CAPECITABINE + IRINOTECAN |
| 270013744 | 270009354 | 1.5 | 53.3 | Curative (C) | 2018-07-24 | 2018-07-29 | DHAP | N | N | 270015612 | DHAP |
| 270013745 | 270009355 | null | 64 | Palliative (P) | 2013-07-30 | 2013-07-30 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270015616 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013746 | 270018365 | 1.71 | 0 | Adjuvant (A) | null | 2018-06-08 | Capecitabine (14 day) + Irinotecan | 02 | null | 270015617 | CAPECITABINE + IRINOTECAN |
| 270013747 | 270009357 | 1.71 | 46.2 | Curative (C) | 2016-03-02 | 2016-03-05 | Trifluridine + Tipiracil | N | Y | 270015618 | TRIFLURIDINE + TIPIRACIL |
| 270013748 | 270009358 | 1.98 | 80.75 | Adjuvant (A) | 2016-10-16 | 2016-10-16 | Capecitabine 35days + RT | N | N | 270015624 | CAPECITABINE + RT |
| 270013749 | 270016901 | 1.76 | 90.2 | Curative (C) | 2014-09-04 | 2014-09-08 | CAPECITABINE + RT | 2 | N | 270015627 | CAPECITABINE + RT |
| 270013750 | 270009360 | 1.92 | 57 | Curative (C) | null | 2014-10-04 | CHOP R - 21 days | N | N | 270015628 | CHOP R |
| 270013751 | 270014373 | 1.77 | 90 | Curative (C) | 2013-09-11 | 2013-09-11 | Shamash LBCMVD-56 | N | Y | 270015629 | NOT MATCHED |
| 270013752 | 270009361 | 1.72 | 86.9 | Neo-adjuvant (N) | 2017-06-08 | 2017-06-09 | Capecitabine 42days + RT | 02 | N | 270015630 | CAPECITABINE + RT |
| 270013753 | 270016902 | 1.53 | 84.4 | Adjuvant (A) | 2015-06-30 | 2015-07-02 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 270015635 | FLUOROURACIL |
| 270013757 | 270009363 | 1.83 | 73.8 | Curative (C) | 2014-01-29 | 2014-01-29 | CHLVPP | N | N | 270015645 | CHLVPP |
| 270013758 | 270009364 | 1.71 | 48 | null | 2017-04-03 | 2017-04-09 | Bevacizumab + Oxaliplatin +MdG | N | N | 270015646 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013759 | 270009365 | 1.55 | 101 | Not known (9) | 2013-09-25 | 2013-09-30 | FLUOROURACIL + FOLINIC ACID | 2 | null | 270015651 | FLUOROURACIL |
| 270013760 | 270016905 | null | null | null | null | 2015-10-09 | Fluorouracil + Folinic Acid Weekly | N | N | 270015652 | FLUOROURACIL |
| 270013761 | 270009366 | 1.76 | 70.1 | Palliative (P) | 2015-04-05 | 2015-04-05 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270015653 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270013762 | 270016906 | 1.92 | 73.8 | Curative (C) | 2018-05-15 | 2018-05-18 | ATG + Amsacrine + BUSULFAN + CYTARABINE + FLUDARABINE | N | N | 270015655 | NOT MATCHED |
| 270013763 | 270009370 | null | null | Curative (C) | 2015-05-24 | 2015-05-31 | null | N | N | 270015661 | NOT MATCHED |
| 270013764 | 270009371 | 1.73 | 80 | Not known (9) | 2015-12-26 | 2016-01-02 | Fluorouricil + Folonic Acid (MdG) | N | N | 270015661 | FLUOROURACIL |
| 270013765 | 270009373 | null | 25.4 | Curative (C) | 2016-01-29 | 2016-01-29 | Cetuximab + Radiotherapy Maint | null | null | 270015666 | CETUXIMAB + RT |
| 270013766 | 270009373 | 1.71 | null | Neo-adjuvant (N) | 2016-07-02 | 2016-07-09 | Trifluridine + Tipiracil | 02 | N | 270015666 | TRIFLURIDINE + TIPIRACIL |
| 270013767 | 270009373 | 1.77 | 85.799 | Curative (C) | 2013-08-02 | 2013-08-02 | CHLVPP | N | Y | 270015666 | CHLVPP |
| 270013768 | 270009374 | null | null | Not known (9) | 2015-10-03 | 2015-10-10 | Fluorouracil + Folinic Acid Weekly | N | N | 270015678 | FLUOROURACIL |
| 270013769 | 270009375 | null | 72 | Adjuvant (A) | 2015-06-01 | 2015-06-16 | Capecitabine (21 day) + Irinotecan | 02 | N | 270015679 | CAPECITABINE + IRINOTECAN |
| 270013770 | 270014382 | 1.75 | 66 | Palliative (P) | 2017-05-28 | 2017-06-02 | Capecitabine (14 day) + Irinotecan | N | N | 270015679 | CAPECITABINE + IRINOTECAN |
| 270013771 | 270009376 | null | 64.3 | Neo-adjuvant (N) | 2013-07-09 | 2014-05-15 | Trifluridine + Tipiracil | 02 | N | 270015689 | TRIFLURIDINE + TIPIRACIL |
| 270013772 | 270009377 | 1.82 | 57.2 | Not known (9) | 2018-02-21 | 2018-03-06 | FLUOROURACIL | N | N | 270015692 | FLUOROURACIL |
| 270013773 | 270009380 | 1.61 | 88.9 | Curative (C) | 2014-06-16 | 2014-07-02 | DHAP | 2 | N | 270015700 | DHAP |
| 270013774 | 270009381 | 1.47 | 90 | Adjuvant (A) | 2017-02-27 | 2017-03-04 | Capecitabine (14 day) + Irinotecan | N | N | 270015701 | CAPECITABINE + IRINOTECAN |
| 270013775 | 270014385 | 1.77 | 71 | Adjuvant (A) | 2015-09-22 | 2015-09-30 | Capecitabine (21 day) + Irinotecan | N | N | 270015702 | CAPECITABINE + IRINOTECAN |
| 270013776 | 270014385 | 1.79 | null | Curative (C) | 2014-08-30 | 2014-09-06 | CHLVPP | N | null | 270015702 | CHLVPP |
| 270013777 | 270019669 | null | 68.5 | Palliative (P) | 2014-01-04 | 2015-07-06 | Trifluridine + Tipiracil | N | N | 270015706 | TRIFLURIDINE + TIPIRACIL |
| 270013778 | 270014386 | 1.61 | 62 | Not known (9) | 2016-10-13 | 2016-10-21 | Fluorouracil + Folinic Acid Weekly | N | N | 270015714 | FLUOROURACIL |
| 270013779 | 270019201 | 1.65 | null | Curative (C) | 2017-04-02 | 2017-04-15 | DHAP | N | null | 270015716 | DHAP |
| 270013780 | 270016912 | 1.71 | 93 | null | 2014-12-15 | 2015-02-10 | Capecitabine (14 day) + Irinotecan | N | N | 270015717 | CAPECITABINE + IRINOTECAN |
| 270013781 | 270009385 | null | null | Palliative (P) | 2016-09-25 | 2016-10-02 | Trifluridine + Tipiracil | 2 | N | 270015720 | TRIFLURIDINE + TIPIRACIL |
| 270013782 | 270009385 | 1.65 | 70.8 | Not known (9) | 2017-06-08 | 2017-11-11 | Fluorouricil + Folonic Acid (MdG) | 2 | N | 270015720 | FLUOROURACIL |
| 270013783 | 270009386 | 1.61 | 147 | Curative (C) | 2017-02-19 | 2017-02-19 | CHLVPP | N | null | 270015721 | CHLVPP |
| 270013784 | 270009386 | 1.87 | 71 | Curative (C) | 2017-06-08 | 2017-06-11 | Trifluridine + Tipiracil | N | N | 270015721 | TRIFLURIDINE + TIPIRACIL |
| 270013785 | 270018373 | 1.62 | 96.2 | Neo-adjuvant (N) | 2016-12-03 | 2016-12-09 | Cetuximab + Radiotherapy Maint | 02 | N | 270015729 | CETUXIMAB + RT |
| 270013786 | 270018373 | 1.8 | 47.5 | Curative (C) | 2014-03-17 | 2013-12-31 | CHOP R - 21 days | null | null | 270015729 | CHOP R |